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The matrix of the constructs had resultant matrix of type II collagen
and proteogrycan which conﬁrmed histochemically. The constructs
formed via cell condensation at 107cells/cm2 grew in thickness
until the day 14 of P1 culture. They grew in size until the day 28 of
P1 culture.
The tissues were stained strongly with safraninO, and there were
partially columnar pattern. Immunohistochemical analysis revealed
that typeIIcollagen was abundantly deposited in the tissue. More-
over with toluidine blue staining, there was a metachromatic matrix.
Interestingly, LIPUS group was also more strongly stained than
sham group by histology.
In vivo study, histology of repair tissue with the chondrocyte plate
in 2wks was not signiﬁcant different about LIPUS group and non-
treated LIPUS (sham) group. But the treated by the plate group,
LIPUS and sham group, were repaired better than control group
by histology.
Conclusions: The chondrocytes of P1 cells prepared at
107cells/cm2 developed into the scaffold-free chondrocyte plate
which was similar to native cartilage under existing cell-cell inter-
actions.
As a result for application of LIPUS, we could stimulate the matrix
synthesis of the scaffold-free chondrocytes plate in vitro study.
In vivo study, we didn’t show the effect of LIPUS to stimulate the
matrix synthesis of the plate.
175
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Purpose: Chondrocyte hypertrophic differentiation is an essential
process during endochondral bone formation, however it hampers
the application of many cartilage regenerative techniques and may
play a role at the onset of osteoarthritis. Clinically, heterotopic bone
formation after orthopaedic surgery is suppressed by non-steroidal
anti-inﬂammatory drugs (NSAIDs) and recent studies point to an
essential role of Cyclooxygenase-2 (COX-2) in osteocytes during
endochondral ossiﬁcation. COX-2 and its metabolite PGE2 are
thought to regulate the function of bone morphogenic protein-2
(BMP-2) and vice versa, which might provide an explanation for
the role of COX-2 during endochondral ossiﬁcation.
In this study, we aim to determine the involvement of COX-
2 in chondrocyte hypertrophy and provide an explanation for
the suppressive effect of NSAIDs on heterotopic ossiﬁcation and
fracture healing.
Methods: To study the role of COX-2 during endochondral ossiﬁ-
cation, ATDC5 cells were differentiated in the chondrogenic lineage
in the presence of BMP-2 for 14 days. The NSAIDs indomethacin
(COX-1/COX-2) or NS398 (COX-2 speciﬁc) were used to inhibit
COX-activity. Expression analysis was performed by RT-qPCR and
western blot (Collagen II, Collagen X, RunX2, COX-2, BMP-2).
Growth curves were obtained from increasing indomethacin- and
NS398-concentrations. Cell numbers were determined by X-violet
staining. Rabbit periosteal grafts were differentiated for 3 weeks
in an agarose sandwich in the presence of BMP-2 (30 ng/nl) and
indomethacin (2 μM) or NS398 (2 μM). Differentiated grafts were
harvested for RT-qPCR and (immuno-)histological analysis. PGE2
production in medium was measured using a speciﬁc ELISA.
Results: Hypertrophic differentiation of ATDC5 cells was obvious
from day 14. Chondrogenesis was accompanied by upregulation of
COX-2 and addition of BMP2 (30 ng/ml) lead to increased upreg-
ulation of COX-2 expression and PGE2 in the media. Accordingly,
expression of Collagen X was also signiﬁcantly upregulated. COX-
2 activity was completely inhibited by indomethacin or NS398.
Surprisingly, speciﬁc inhibition of COX-2 by NS398 did not affect
Collagen II expression whereas expression of RunX2 and Colla-
gen X was signiﬁcantly decreased in a concentration dependent
way. COX-inhibition by indomethacin showed similar results, how-
ever had inhibitory effects on Collagen II expression at higher
concentrations. Expression of BMP-2 decreased upon increasing
NSAID concentrations, conﬁrming a functional connection be-
tween COX-2 and BMP-2. To determine whether COX-inhibition
speciﬁcally affects differentiation, proliferation rate of ATDC5 cells
under proliferating and differentiating conditions was determined.
No signiﬁcant effect on proliferation was detected. Chondrocyte
hypertrophy of periosteal grafts was dependent on BMP-2. This
BMP-2 mediated hypertrophy was suppressed by COX-inhibition
as determined by ELISA, RT-qPCR and histological analysis, con-
ﬁrming our ﬁndings in ATDC5 cells.
Conclusions: Our data show that COX-2 is upregulated during
chondrogenesis and that BMP-2 induces chondrocyte hypertrophy
and COX-2 expression, suggesting a functional connection. Using
two independent systems we were able to show that inhibition of
COX-activity decreased chondrocyte hypertrophy. Insight into the
mechanism by which COX-2 inﬂuences endochondral ossiﬁcation
is essential to understand the effect of NSAIDs on fracture healing.
Our data may provide a novel strategy to improve the outcome of
cartilage regenerative medicine.
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Purpose: Mesenchymal stem cells (MSCs) have been identiﬁed
in human synovial membrane and articular cartilage from patients
with osteoarthritis (OA), but detailed quantiﬁcation studies of MSCs
were not performed. The purpose of this study was to quantitatively
measure the expression of MSC markers in synovial membranes
from human OA (OA) and health joints.
Methods: Synovial membrane-derived cells were isolated from
health and OA joints and characterized by ﬂow cytometry for
hematopoietic (CD34 and CD45) and mesenchymal (CD44, CD29,
CD73, CD90, CD105 and CD271) markers. Chondrogenesis was
assessed by staining for proteoglycans and type II collagen, adi-
pogenesis by using a stain for lipid drops and osteogenesis by
detecting calcium deposits. The co-expression of CD44, CD90,
CD105 and CD271 was determined by immunoﬂuorescence in
OA and normal synovial membranes and spontaneous cartilage
repair.
Results: More than 90% of OA synovial membrane-derived cells
were positive for CD44, CD73, and CD90 and negative for CD34
and CD45. OA synovial membrane-derived cells were also pos-
itive for CD29 (85.23%), CD117 (72.35%) and CD105 (45.5%).
Micropellet analyses showed that culture of the cells with TGF-
beta3 stimulated proteoglycan and type II collagen synthesis.
Synovial membrane-derived cells culture developed lipid droplets
in adipogenic medium and calciﬁcation in oteogenic medium. Cells
positive for MSC markers were diffusely distributed in OA synovial
membranes. In health synovia, these cells were localized in the
subintimal zone. The number of cells expressing MSCs markers
was higher in OA synovial membranes than in synovia from nor-
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mal joints (6.1% vs. 2.2%), corresponding the highest percentage
of cellular expression to the co-expression of CD90/CD271 (9.8%
vs. 2.6%). Spontaneous repair tissue contained cells positive for
CD44 (12.3%), CD90 (10.4%) and CD271 (9.9%) antigens, but
the CD105 antigen was absent.
Conclusions: These results suggest that during the OA process
an increment of MSC percentage occur in synovial membrane.
Absent expression of the CD105 antigen in the OA cartilage repair
indicates that cells expressing this marker may be necessary for
effective repair processes in OA cartilage.
This study was supported by grants from Secretaría Xeral de I+D,
Xunta de Galicia PGIDIT05SAN08PR, PGIDIT04PXIC91602PN,
PGIDIT04PXIC91601PN, FISCP03/00127 and FIS05/2495; Fun-
dación Española de Reumatología.
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Purpose: Mesenchymal stem cells (MSCs) are considered as a
potential cell therapy to treat a variety of rheumatic diseases.
MSCs are widely distributed in the body, including bone marrow
(BM). Chondrogenic differentiation process involves the differ-
entiation of MSCs towards cartilage or bone. Cartilage tissue
engineering uses efﬁcient protocols that suppress differentiation
towards hypertrophic chondrocytes, providing a useful in vitro
model for studying the gene regulation of chondrogenesis and
cartilage development. This model may provide new molecular
targets for rheumatic diseases treatment. The aim of this study
was investigate the transcriptional regulation of genes implicated in
the different steps of chondrogenesis in normoxia versus hypoxia
conditions.
Methods: MSCs, isolated from 5 BM were expanded in monolayer.
CD105+ and CD105- cells were separated from total BM by MACS
Technology (Miltenyi Biotec, Spain) and their phenotype were char-
acterized by ﬂow cytometry. The three populations of MSCs (total
BM, CD105+ and CD105- BM) were subjected to chondrogenesis
by means of high-density 3D aggregate culture in normoxia and
hypoxia conditions. Chondrogenesis was studied at different inter-
vals of time: 0, 2, 4, 7, 14, 21, and 28 days and differentiation
was conﬁrmed by histochemistry (hematoxylin-eosin, Masson’s
thrichome, alcian blue, safranin O), immunohistochemistry (types
II and I collagens, and aggrecan) and quantitative real Time PCR
(qPCR) techniques. For qPCR experiments RNAs were isolated
using Trizol reagent (Invitrogen, Spain). Different primers were
designed to study mRNA expression of different genes implicated
in the different stages of chondrogenesis (MSCs, condensation
& chondroprogenitors, chondrocytes and prehypertrophic chon-
drocytes).These primers included Sox2, Nanog, OCT3/4, CDH2,
TNC, Sox9, Agg, Col I, Col II, Col X and RunX2.
Results: At the starting point of the experiments, the stem cell
phenotype markers (SOX2, Nanog and OCT3/4) showed higher
expression levels in the CD105+ population. At 14-28 days in
hypoxia and at 21-28 days in normoxia the expression levels
of Nanog and OCT3/4 showed to be higher in the total bone
marrow and CD105- populations. Instead, the level of SOX2 at
the same times of the experiment showed to be higher in the
CD105+ population. These markers remained expressed until day
28, both in normoxia and in hypoxia, indicating that not all the stem
cells were differentiated towards chondrocytes but some of them
remained in a state of indifferentiation. With regard to cartilage
speciﬁc markers, the CD105- population showed increased levels
of SOX9 and AGG mRNA than CD105 + and total bone marrow
ones, however the latter showed the highest expression levels of
Col II followed by CD105- and CD105 + populations. In this way,
the overexpression of Col II in hypoxia was accentuated between
7 and 21 days while in normoxia took place from 14 to 28 days.
Conclusions: Hypoxia accelerates the chondrogenic differentia-
tion process from bone marrow-derived adult mesenchymal stem
cells to mature chondrocytes. Isolation of CD105 + and CD105-
populations shows no improvement in chondrogenesis with regard
to the total bone marrow population.In addition, while the CD105+
population seems to differentiate in the experimental conditions,
the CD105- one shows to remain in an indifferentiated state, main-
tening an important expression of SOX2, NANOG and OCT3/4
genes.
C Cicione: Fellowship Univ. Rome "Sapienza". Contract-
Foundation CHU A Coruña, Spain. E Muiños: Fellowship Rheum.
Spanish Foundation. S Diaz: "Isidro Parga Pondal" - Xunta Galicia,
Spain.
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The current surgical procedures used to treat the degenerate inter-
vertebral disc (IVD) are inadequate. Vertebral fusion can frequently
reduce back pain, but does not preserve motion segmental mo-
bility and thus may lead to subsequent degeneration in adjacent
motion segments. In contrast, artiﬁcial disc prostheses preserve
mobility, but in the long-term may result in serious complications
due to wear, loosening, subsidence or mechanical failure. Bio-
logical repair of the degenerate IVD could provide a means of
overcoming these problems. In vitro organ culture models using
large IVDs have recently been described for this purpose, but
they have suffered from the inability to achieve long-term NP cell
viability, due to impaired nutrient supply because of endplate cal-
ciﬁcation and the postmortem formation of blood clots blocking the
trans-endplate nutrition path.
Purpose: To develop a bovine coccygeal IVD organ culture model
of disc degeneration with long-term cell survival, in which induced
biological repair can be studied.
Methods: IVDs were isolated from bovine tails by parallel cuts
through the adjacent vertebral bodies, and remaining bone and
most of the cartilage endplates were removed using a high-speed
bone burr. The explants were maintained in culture in DMEM,
supplemented with 5% FBS and antibiotics, with medium changed
twice weekly. Degeneration was induced by injecting trypsin into
the center of the NP. Cell viability was monitored in a 1 mm slice
through the center of the disc, using a live/dead ﬂuorescence
assay (Live/Dead®, Invitrogen) and confocal microscopy. Tissue
morphology was examined by histology. Annulus ﬁbrosus (AF)
and nucleus pulposus (NP) were extracted using 15 volumes
4M GuHCl containing protease inhibitors, and changes in the
abundance and degradation of chondroadherin and ﬁbromodulin
were analysed by immunoblotting. GAG content was measured
using the DMMB assay.
Results: Intact bovine discs maintained in free swelling culture
with no external load applied demonstrated cell viability for up to
6 weeks. The amount of GAG retained in the tissue decreased
slowly during the culture period and cell clustering reminiscent of
cartilage and disc degeneration was found. As it is not practical
to wait for 4-6 weeks before repair potential of various treatments
